Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax Inc (NQ: NVAX )

5.530 -0.050 (-0.90%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,705,639
Open 5.580
Bid (Size) 5.510 (16)
Ask (Size) 5.550 (10)
Prev. Close 5.580
Today's Range 5.420 - 5.590
52wk Range 5.300 - 18.55
Shares Outstanding 74,484,166
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is Novavax Stock a Buy Now?
The company's shares may look cheap on the surface, but don't be too quick to jump in. 
Via The Motley Fool
3 Short-Squeeze Stocks That Could Take Off Before Year-End
These three short-squeeze stocks are seeing high short interest. They each could see a year-end short squeeze and notable market moves. 
Via InvestorPlace

Performance

YTD
-43.51%
-43.51%
1 Month
-22.00%
-22.00%
3 Month
-39.56%
-39.56%
6 Month
-31.39%
-31.39%
1 Year
-67.89%
-67.89%

More News

Read More
What's Going On With Novavax Stock Tuesday?
Via Benzinga
Could a Short Squeeze Be Coming for These 3 Heavily Shorted Stocks?
Via The Motley Fool
Where Will Novavax Be in 3 Years?
Via The Motley Fool
Novavax Prepares Further Cost Cuts To Better Align With Demand-Challenged COVID-19 Vaccine Market
Via Benzinga
Exposures COVID-19
Novavax's Earnings: A Preview
Via Benzinga
The Fall Vaccination Season Is Here. Is Novavax a Buy?
Via The Motley Fool
Wall Street To Snap Longest Winning Streak Since 2021 Today? Earnings, Bond Yields In Focus Ahead Of Powell's Speech
Via Benzinga
Down 75% From Its High, Has Novavax Stock Become Too Cheap to Pass Up?
Via The Motley Fool
Moderna Beats Sales Forecasts, But Light Guidance Could Rattle Shares
Via Investor's Business Daily
7 Dangerous Stocks to Avoid No Matter What
Via InvestorPlace
Top 6 Nasdaq Short Squeeze Play Stocks
Via Talk Markets
Pfizer Reportedly Hikes Paxlovid Price To $1,390 — More Than Double What The Government Paid
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Do These 5 Words From Pfizer Mean Trouble for Novavax?
Via The Motley Fool
Exposures COVID-19
Bitcoin's ETF Approval Rumor, Pfizer Slashes Annual Outlook, Activist Shareholder Shakes Up News Corp's Status Quo: Today's Top Stories
Via Benzinga
Topics ETFs
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Moderna, BioNTech Lead Covid Sell-Off After Pfizer Slashes Its Outlook By $9 Billion
Via Investor's Business Daily
Exposures COVID-19
Novavax Faces Setback, European Authority Delays Decision On Variant-Tailored COVID-19 Vaccine
Via Benzinga
Exposures COVID-19
The 10 Most Shorted Stocks Include 3 Tesla Rivals, But Not TSLA
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
US Stocks On Track For A Strong Start To Week, Buoyed By Earnings Optimism: Analyst Flags 13-14% Upside As Bull Market Enters Its Second Year
Via Benzinga
BioNTech, Moderna And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Is Novavax Stock a Buy Now?
Via The Motley Fool
Novavax (NVAX) Stock Slides Despite Vaccine Availability
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.